Ron Cohen

2015

In 2015, Ron Cohen earned a total compensation of $3.4M as President and Chief Executive Officer at Acorda Therapeutics, a 15% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$553,728
Option Awards$1,510,794
Salary$768,750
Stock Awards$607,580
Other$7,950
Total$3,448,802

Cohen received $1.5M in option awards, accounting for 44% of the total pay in 2015.

Cohen also received $553.7K in non-equity incentive plan, $768.8K in salary, $607.6K in stock awards and $8K in other compensation.

Rankings

In 2015, Ron Cohen's compensation ranked 2,645th out of 13,638 executives tracked by ExecPay. In other words, Cohen earned more than 80.6% of executives.

ClassificationRankingPercentile
All
2,645
out of 13,638
81st
Division
Manufacturing
937
out of 5,190
82nd
Major group
Chemicals And Allied Products
343
out of 1,854
82nd
Industry group
Drugs
269
out of 1,528
82nd
Industry
Biological Products, Except Diagnostic Substances
47
out of 254
82nd
Source: SEC filing on April 21, 2017.

Cohen's colleagues

We found six more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2015.

2015

Jane Wasman

Acorda Therapeutics

General Counsel

2015

Enrique Carrazana

Acorda Therapeutics

Chief Medical Officer

2015

Michael Rogers

Acorda Therapeutics

Chief Financial Officer

2015

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2015

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

2015

Andrew Hindman

Acorda Therapeutics

Chief Business Development Officer

News

You may also like